Lichen China Limited's 6-K Report: Major Changes Ahead!

$LICN
Form 6-K
Filed on: 2025-02-12
Source
Lichen China Limited's 6-K Report: Major Changes Ahead!

Key Information Extracted from Lichen China Limited's 6-K Filing

Company Profile

  • Name: Lichen China Limited
  • Address: 15th Floor, Xingang Square, Hubin North Road, Siming District, Xiamen City, Fujian Province, China, 361013
  • Commission File No: 001-41493

Annual Meeting of Shareholders

  • Date and Time: February 10, 2025, at 09:00 PM China Time (08:00 AM Eastern Time).
  • Quorum:
  • Class A Ordinary Shares: 1,893,052 shares present, representing 2.9% of voting power.
  • Class B Ordinary Shares: 9,000,000 shares present, representing 100% of voting power.
  • Voting Power: Class B shares carry 10 votes per share.

Resolutions Approved

  1. Share Capital Increase:
  • Authorized share capital increased from $50,000 to $1,000,000.
  • Additional shares created: 19,000,000,000 Class A and 4,750,000,000 Class B ordinary shares.
  1. Share Consolidation:
  • Approved consolidation at a ratio between 1-for-20 and 1-for-200, with the exact ratio to be determined by the Board.
  1. Amendment to Memorandum and Articles:
  • Amendments approved to reflect the share capital increase and consolidation.
  1. Change of Company Name:
  • Change from "Lichen China Limited" to "Lichen International Limited."
  1. Amendment of Articles of Association:
  • Article 62 amended to allow for electronic and telephonic voting.
  1. Adjournment of Meeting:
  • Approved adjournment if necessary to further solicit votes for the proposed resolutions.

Voting Results Summary

  • Proposal #1 (Share Capital Increase):
  • For: 99.33%, Against: 0.66%
  • Proposal #2 (Share Consolidation):
  • For: 99.35%, Against: 0.64%
  • Proposal #3 (Adoption of New Memorandum):
  • For: 99.31%, Against: 0.66%
  • Proposal #4 (Adoption of New Articles for Share Consolidation):
  • For: 99.34%, Against: 0.65%
  • Proposal #5 (Change of Name):
  • For: 99.64%, Against: 0.35%
  • Proposal #6 (Amendment of Articles):
  • For: 99.36%, Against: 0.63%
  • Proposal #7 (Adjournment):
  • For: 99.21%, Against: 0.78%

Additional Notes

  • The Amended and Restated Memorandum and Articles of Association filed as Exhibit 3.1.
  • The report is signed by Ya Li, Chief Executive Officer, on February 12, 2025.

Summary Insights

  • The company is undergoing significant structural changes including a large increase in authorized share capital and a name change, which may indicate a strategic shift to expand operations or enhance market presence.
  • Strong support from shareholders is evident, with proposals receiving overwhelming approval rates, suggesting a united front towards the company's future direction.

This filing is crucial as it reflects Lichen China Limited's governance and strategic decisions moving forward.